Browsing Over 107 Presentations

Sort By
Biomarkers in clinical practice and future perspective for gynaecological cancers Special session

Should we really use PD-L1 as a selection driver in cervical cancer?

Lecture Time
10:30 - 10:50
Speakers
  • Bradley J. Monk (Phoenix, AZ, United States of America)
Session Name
Biomarkers in clinical practice and future perspective for gynaecological cancers
Room
Auditorium 1A
Date
Fri, 17.06.2022
Time
10:30 - 12:00
Biomarkers in clinical practice and future perspective for gynaecological cancers Special session

MMR status, TMB or both: How to identify endometrial cancer patients who benefit the most from immunotherapy

Lecture Time
10:50 - 11:10
Speakers
  • Vicky Makker (New York City, NY, United States of America)
Session Name
Biomarkers in clinical practice and future perspective for gynaecological cancers
Room
Auditorium 1A
Date
Fri, 17.06.2022
Time
10:30 - 12:00
Biomarkers in clinical practice and future perspective for gynaecological cancers Special session

Digging into molecular characterization of high-grade ovarian cancer: BRCA, HRD and beyond

Lecture Time
11:10 - 11:30
Speakers
  • Nicole Concin (Innsbruck, Austria)
Session Name
Biomarkers in clinical practice and future perspective for gynaecological cancers
Room
Auditorium 1A
Date
Fri, 17.06.2022
Time
10:30 - 12:00
Biomarkers in clinical practice and future perspective for gynaecological cancers Special session

The role of MAPK pathway to select therapy in low-grade ovarian cancer

Lecture Time
11:30 - 11:50
Speakers
  • Susana Banerjee (London, United Kingdom)
Session Name
Biomarkers in clinical practice and future perspective for gynaecological cancers
Room
Auditorium 1A
Date
Fri, 17.06.2022
Time
10:30 - 12:00
Biomarkers in clinical practice and future perspective for gynaecological cancers Special session

Live Q&A

Lecture Time
11:50 - 12:00
Speakers
  • Bradley J. Monk (Phoenix, AZ, United States of America)
Session Name
Biomarkers in clinical practice and future perspective for gynaecological cancers
Room
Auditorium 1A
Date
Fri, 17.06.2022
Time
10:30 - 12:00
Clinical trial highlights Special session

Efficacy and safety of niraparib as maintenance treatment in patients with newly diagnosed advanced ovarian cancer using an individualized starting dose (PRIME Study): A randomized, double-blind, placebo-controlled, phase III trial

Lecture Time
10:30 - 10:40
Speakers
  • Ning Li (Beijing, China)
Session Name
Clinical trial highlights
Room
Auditorium 1A
Date
Sat, 18.06.2022
Time
10:30 - 12:00
Clinical trial highlights Special session

ATHENA (GOG-3020/ENGOT-ov45): A randomized, phase III trial to evaluate rucaparib as monotherapy (ATHENA-MONO) and rucaparib in combination with nivolumab (ATHENA-COMBO) as maintenance treatment following frontline platinum-based chemotherapy in ovarian cancer

Lecture Time
10:40 - 10:50
Speakers
  • Rebecca Kristeleit (London, United Kingdom)
Session Name
Clinical trial highlights
Room
Auditorium 1A
Date
Sat, 18.06.2022
Time
10:30 - 12:00
Clinical trial highlights Special session

Invited Discussant of PRIME and ATHENA-MONO studies

Lecture Time
10:50 - 11:05
Speakers
  • Mansoor Raza Mirza (Copenhagen, Denmark)
Session Name
Clinical trial highlights
Room
Auditorium 1A
Date
Sat, 18.06.2022
Time
10:30 - 12:00
Clinical trial highlights Special session

Live Q&A

Lecture Time
11:05 - 11:15
Speakers
  • Susana Banerjee (London, United Kingdom)
Session Name
Clinical trial highlights
Room
Auditorium 1A
Date
Sat, 18.06.2022
Time
10:30 - 12:00
Clinical trial highlights Special session

SIENDO/ENGOT-EN5: A randomized phase III trial of maintenance with selinexor/placebo after combination chemotherapy in patients with advanced or recurrent endometrial cancer

Lecture Time
11:15 - 11:25
Speakers
  • Vicky Makker (New York City, NY, United States of America)
Session Name
Clinical trial highlights
Room
Auditorium 1A
Date
Sat, 18.06.2022
Time
10:30 - 12:00
Clinical trial highlights Special session

MITO 23: A randomized phase III trial on trabectedin vs physician choice chemotherapy in BRCA mut and BRCAness ovarian cancer

Lecture Time
11:25 - 11:35
Speakers
  • Domenica Lorusso (Rome, Italy)
Session Name
Clinical trial highlights
Room
Auditorium 1A
Date
Sat, 18.06.2022
Time
10:30 - 12:00
Clinical trial highlights Special session

Invited Discussant of SIENDO/ENGOT-EN5 and MITO 23 studies

Lecture Time
11:35 - 11:50
Speakers
  • Isabelle L. Ray-Coquard (Lyon, France)
Session Name
Clinical trial highlights
Room
Auditorium 1A
Date
Sat, 18.06.2022
Time
10:30 - 12:00